Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15)

Cancer Letters

Volumn 278, Issue 1, 2009, Pages 104-112

  Cai, Mingjun ^a   Han, Lin ^a   Chen, Rudong ^a   Ye, Fei ^a   Wang, Baofeng ^a   Han, Fuxin ^a   Lei, Ting ^a   Guo, Dongsheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

EGFR; GL15; Glioma; LRIG3; RNAi

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA TEMPLATE; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LRIG3 GENE; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM NEOPLASMS; GLIOBLASTOMA; GLIOMA; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

EID: 63449093719     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.001     Document Type: Article

References (23)

1. Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3 (2003) 362-374
2. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3 (2003) 489-501
3. Fire A., Xu S.Q., Montgomery M.K., Kostas S.A., Drive S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
4. Novina C.D., and Sharp P.A. The RNAi revolution. Nature 430 (2004) 161-164
5. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
6. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
7. Nilsson J., Vallbo C., Guo D.S., Golovleva I., Hallberg B., Henriksson R., and Hedman H. Cloning characterization and expression of human LIG1. Biochem. Biophys. Res. Commun. 284 (2001) 1155-1161
8. Holmlund C., Nilsson J., Guo D.S., starefeldt A., Golovleva I., Henriksson R., and Hedman H. Characterization and tissue-specific expression of human LRIG2. Gene 332 (2004) 33-35
9. Guo D.S., Holmlund C., Henriksson R., and Hedman H. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 84 (2004) 157-165
10. Hedman H., Nilsson J., Guo D.S., and Henriksson R. Is LRIG1 a tumor suppressor gene at chromosome 3p143?. Acta Oncol. 41 (2002) 352-354
11. Suzuki Y., Sato N., Tohyama M., Wanaka A., and Takagi T. cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain LIG-1 a protein with leucine-rich repeats and immunoglobulin-like domains. J. Biol. Chem. 271 (1996) 22522-22527
12. Suzuki Y., Miura H., Tanemura A., Kobayashi K., Kondoh G., Tohyama M., et al. Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett. 521 (2002) 67-71
13. Nilsson J., Starefeldt A., Henriksson R., and Hedman H. LRIG1 protein in human cells and tissues. Cell Tissue Res. 312 (2003) 65-71
14. Reifenberger G., Ichimura K., Reifenberger J., Elkahloun A.G., Meltzer P.S., and Collins V.P. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res. 56 (1996) 5141-5145
15. Mischel P.S., Shai R., Shi T., Horvath S., Lu K.V., Choe G., Seligson D., Kremen T.J., Palotie A., Liau L.M., Cloughesy T.F., and Nelson S.F. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22 (2003) 2361-2373
16. Yuan B.B., Latek R., Hossbach M., Tuschl T., and Lewitter F. siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32 (2004) 130-134
17. Tuschl T. Expanding small RNA interference. Nature Biotech. 20 (2002) 446-448
18. Gurney J.G., and Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr. Opin. Oncol. 13 (2001) 160-166
19. Fine H.A. The basis for current treatment recommendations for malignant gliomas. J. Neurooncol. 20 (1994) 111-120
20. Ghiglione C., Carraway K.L., Amundadottir L.T., Boswell R.E., Perrimon N., and Duffy J.B. The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell 96 (1999) 847-856
21. Yarden Y. The EGFR family and its ligands in human cancer: signaling mechanisms and therapeutic opportunities. Eur. J. Cancer 37 (2001) 3-8
22. Andersson U., Guo D.S., Malmer B., Bergenheim A.T., Brännström T., Hedman H., and Henriksson R. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol. 108 (2004) 135-142
23. Nathoo N., Goldlust S., and Vogelbaum M.A. Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas. Neurosurgery 54 (2004) 1480-1488